GAfPA Blog

The GAfPA Patient Advocacy Blog

Rheumatoid Arthritis Patients Want Tools for Shared Medical Decision-Making

When it comes to shared medical decision-making, European patients with rheumatoid arthritis are open to ideas.   A recent patient questionnaire from the European Alliance for Patient Access revealed that patients don’t always find it easy to talk with their doctor or nurse about their symptoms, treatment and quality of life with rheumatoid arthritis.  And … Continued

Survey Highlights Desire for Innovation in Latin America

Central and South American governments should consider new policies that support innovation in health care and improve patient access, according to results from a survey recently conducted by the Global Alliance for Patient Access.

Encuesta destaca el deseo de impulsar innovación en América Latina

Según los resultados de una encuesta realizada recientemente por la Alianza Global para el Acceso de Pacientes, los gobiernos de América Central y América del Sur deben considerar nuevas políticas que apoyen la innovación en la atención médica y mejoren el acceso a los pacientes.

What Heart Attack & Stroke Mean to EU Workplaces

Heart attack and stroke don’t just affect patients across Europe, new research reveals.  These cardiovascular events also impact the EU’s national economies – by increasing absenteeism and reducing productivity in workplaces across the region. Productivity Loss & Economic Impact Among patients who returned to work, having a heart attack or stroke was associated with losing … Continued

What EU Parliamentary Candidates Need to Know about Heart Health

As the European Union edges toward parliamentary elections, patient advocates have a message for candidates: Prioritise heart health. As outlined in a recently released manifesto from the European Heart Network, a Brussels-based alliance of foundations and associations dedicated to fighting heart disease and stroke, Members of the European Parliament have the opportunity to support investment … Continued

New “Fast Facts” Highlights Impact of High Cholesterol on Europe

More than 50 percent of Europeans have raised cholesterol, increasing their risk of heart attack, stroke and death – and costing the EU billions every year in health care expenses and lost productivity.  So explains a new “Fast Facts” policy brief from the European Alliance for Patient Access, a division of the Global Alliance for … Continued

England Sets Sights on Heart Health

England has a plan.  It’s comprehensive, long term and aimed at preventing 150,000 heart attacks and strokes over the next 10 years.  How? By, among other measures, reducing high cholesterol, hypertension and atrial fibrillation. Recently released by the National Health Service, England’s “Long-Term Plan” outlines national health strategies for a variety of national health needs … Continued

GAfPA’s Statement Supporting the USMCA Signing at the G20 Summit

A new international treaty has important implications for patients’ access to innovative treatments. On November 30, during the G20 Summit in Buenos Aires Argentina, President Trump, Prime Minister Trudeau and President Peña Nieto signed the new U.S. Mexico Canada Agreement. Once approved by the U.S. Congress, this trade deal will replace NAFTA as the free … Continued

GAfPA Statement on United States-Mexico-Canada Agreement

Patients who are eager for the next generation of treatments and cures will be well served by the United States-Mexico-Canada Agreement.  This agreement provides intellectual property protections that promote patient access to innovative medicine, clearing the way for new treatments for cancer, Alzheimer’s, diabetes and many other conditions.

Sign up to receive updates from GAfPA